Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
2021 Standout
9 intermediate papers

Works of C. Kourousis being referenced

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group
2003
Frontline Treatment of Advanced Gastric Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor (G-CSF)
2000
and 2 more

Author Peers

Author Last Decade Papers Cites
C. Kourousis 437 351 184 20 630
Keiichiro Uehara 541 304 128 29 702
Ji Eun Uhm 334 259 113 24 611
Sheldon Kaufman 354 238 244 31 653
Maria D. Begnami 274 213 152 21 543
Michael B. Campion 283 302 374 33 704
María Gómez Galdón 470 151 220 30 701
Santiago Albiol 226 191 329 20 596
Bonnie Shadrach 316 139 137 17 565
Hisao Matsunou 352 202 307 19 589
Marie Alt 537 252 115 19 729

All Works

Loading papers...

Rankless by CCL
2026